MedTrace Logo

ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.

NCT00509392 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2017-07-12

Study results available
· View outcomes & findings →

Summary

The objective of this post-market study is to compare the post-procedure recovery between two types of minimally invasive catheter treatments for venous disease in the Great Saphenous Vein.

Conditions

  • Venous Reflux

Interventions

DEVICE

Seg. RF Ablation & ClosureFAST catheter

Seg. RF Ablation \& ClosureFAST catheter

DEVICE

Endovenous Laser

laser catheter

Sponsors & Collaborators

  • VNUS Medical Technologies, A Covidien Company

    collaborator INDUSTRY

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • Lian Cunningham, MD · VNUS Medical Technologies, A Covidien Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00509392 on ClinicalTrials.gov